Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Pharma Boards Confuse Scenario Models With Risk Measurements
Maman Ibrahim is a cyber and digital risk executive, helping boards, CRO, CIO, and CISO turn risk work into decisions, delivery, and proof. A large number can change the weather in a boardroom. The chair looks up. The CFO stops scrolling. Someone…
Sirio Pharma eyes Australia's gummy supplement market with TGA-compliant range
Sirio Pharma is targeting growth in Australia's gummy supplement market with the launch of a range of Therapeutic Goods Administration (TGA) compliant products.
Orimed Pharma Expands PrLuxa-D™ Portfolio to Enhance Vitamin D Treatment Options in Canada
Orimed Pharma, an affiliate of the JAMP Pharma Group, is expanding the Luxa-D portfolio with new strengths of vitamin D: 5 000, 10 000, 25 000 and 50 000 International Units (IU) These new formulations offer additional dosage options in the…
Can You Support Medicare for All and Take Money From Big Pharma?
The 2026 midterm season has so far been marked by the cost-of-living crisis and a desire to bring in a new guard of spunkier, younger politicians who will fight President Trump. In Colorado's First Congressional District, which includes Denver and…
HAB Pharma merges with Signature Phytochemicals, bolsters manufacturing
HAB Pharma and Signature Phytochemicals have completed their merger, creating an entity with a consolidated turnover of about ₹600 crore. Finalized in March 2026, the merger was undertaken to streamline operations, harmonize corporate…
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?
iShares U.S. Pharmaceuticals ETF (IHE) returned 38% over twelve months to $89 despite Trump's MFN drug pricing order, driven by Eli Lilly (LLY) and AbbVie (ABBV) pipeline catalysts, but concentration risk is acute with Johnson & Johnson and Eli…
Royalty Pharma PLC $RPRX Shares Acquired by Cullen Frost Bankers Inc.
Cullen Frost Bankers Inc. lifted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund…
49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG
Partners Group Holding AG bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 49,855 shares of the…
Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX
Marathon Asset Management Ltd reduced its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned…
UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point
Jazz Pharmaceuticals (JAZZ) received a Buy upgrade from UBS with a $307 price target, reflecting confidence in the company's $1.07B Q1 2026 revenue (up 19% YoY) with adjusted EPS of $6.34 beating consensus estimates. UBS's upgrade signals that Jazz…
Pharmalittle: We're reading about a Supreme Court setback for pharma, TrumpRx expands and much more
Top of the morning to you, and a fine one it is. We can tell because the sun is shining and cool breezes are blowing by the Pharmalot campus, although they may dissipate as temperatures start climbing. Nonetheless, we are celebrating another busy…
Thrivent Financial for Lutherans Acquires 22,015 Shares of Royalty Pharma PLC $RPRX
Thrivent Financial for Lutherans lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 233,320 shares of the…
Atle Fund Management AB Sells 33,426 Shares of BridgeBio Pharma, Inc. $BBIO
Atle Fund Management AB decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 19.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…
UK COVID Inquiry's Endorsement Of Censorship Sets Chilling Precedent
According to the UK's Covid Inquiry, whose fourth report was published in April, there was “in principle, nothing unlawful or inappropriate in the government monitoring publicly available social media to identify potential trends in…
The Hidden Players Powering The Future Of Quantum Computing
Dr. Pravir Malik is the founder and technologist of QIQuantum and the Forbes Technology Council Community leader for Quantum Computing. software developer working at computer The race to build practical quantum computers often dominates headlines…
Receive a Daily briefing on Pharma Industry News
Get Started